Find out if PLEGRIDY could be right for your relapsing MS patients.
The ADVANCE clinical trial examined 3 key measures of disease activity
Review the well-established safety profile and strategies to address tolerability
Find out if dosing with PLEGRIDY may fit into your patient’s routine
Start your patients on treatment
myBiogen is an online resource for starting and keeping patients on therapy